Skip to content

Sunday, October 1, 2023

Latest:

An ounce of prevention: does breastfeeding protect against childhood cancer?
PARMESAN: An AI-based predictive tool to find new treatments for genetic disorders
What is a superfood?
Aortic dissection awareness saves lives: Understanding symptoms, causes, treatment options
Researchers combat Zika-associated fetal abnormalities using microRNA

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

estrogen receptor 1

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

May 16, 2023May 16, 2023 endocrine therapy-resistant breast cancer, ER+ breast cancer, estrogen receptor 1, fusion genes, pralsetinib, Research, RET kinase

The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.

From the Labs Image of the Month

From the Labs: Plasticity of adult-born neurons.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951